跳至主要内容
临床试验/NL-OMON35775
NL-OMON35775尚未招募不适用

Detection and treatment of endobronchial (pre-)malignant lesions after treatment of early stage lung cancer in COPD patients - ProFECT trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 890 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
890

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • T1N0M0 or T2aN0M0 histologically proven NSCLC with a maximum tumor diameter of 4cm, treated with either anatomical surgical resection or SBRT with curative intent within the last six months. T descriptors according to the 7th edition of the TNM classification for lung cancer. ;GOLD II-IV COPD prior to resection.10

排除标准

  • Adjuvant chemo-, immune- or radiotherapy
  • Current or recent (<5 years) cancer other than lung cancer.
  • Chronic respiratory failure, defined as PaO2 <60 mmHg with or without PaCO2 >50 mmHg.10

研究者

相似试验

Detection and treatment of endobronchial... | 临床试验